A phase 2 study of ruxolitinib in combination wi... - MPN Voice

MPN Voice

10,522 members14,537 posts

A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis

Paul123456 profile image
4 Replies

Sounds very encouraging

bloodjournal.org/content/13...

Written by
Paul123456 profile image
Paul123456
To view profiles and participate in discussions please or .
Read more about...
4 Replies
Innessant profile image
Innessant

Thanks for sharing. The arguments of synergies in medicine continue to be a good and " low cost" form of clinical trial. Every bit helps I guess...

Bluetop profile image
Bluetop

Thanks for posting this -sounds positive.

Aneliv9 profile image
Aneliv9

I try hard to understand, IF a treatment that will have a positive outcome on bone marrow fibrosis, will prolong life expectancy or halt the disease progression.. But i can't understand what long-term outcome will have.

Aneliv9 profile image
Aneliv9

This synergetic effects could halt the progression of MF?

You may also like...